Header Logo

VENEE TUBMAN

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 BATES
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Onyebuchi CO, Chumpitazi CE, Placencia JL, Jackson AN, Jones JL, Torres L, Tubman VN, Onyebuchi CO, Chumpitazi CE, Placencia JL, Jackson AN, Jones JL, Torres L, Tubman VN. Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage. J Pain Symptom Manage. 2024 Mar; 67(3):e169-e175. PMID: 38000561.
      Citations:    Fields:    Translation:Humans
    2. Mohandas N, Abrams CS, Tubman VN. New ASH initiatives to improve patient care in the long-overlooked sickle cell disease. Blood. 2023 07 20; 142(3):230-234. PMID: 37216689.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Poventud-Fuentes I, Portillo TP, Olayinka L, Marcogliese AN, Tubman VN, Devaraj S. Unique Hemoglobinopathy Pattern Following Treatment with Voxelotor. Ann Clin Lab Sci. 2023 Jul; 53(4):647-652. PMID: 37625829.
      Citations:    Fields:    Translation:Humans
    4. Ettinger NA, Guffey D, Anum SJ, Fasipe T, Katkin J, Bhar S, Airewele G, Saini A, Tubman VN. Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States. Sci Rep. 2023 04 25; 13(1):6758. PMID: 37185357; PMCID: PMC10130031.
      Citations:    Fields:    Translation:Humans
    5. Udhayashankar K, Franklin PD, Nuta CJ, Cherue AK, Haq H, Thompson D, Tubman VN. Determinants of retention in care of newborns diagnosed with sickle cell disease in Liberia: Results from a mixed-methods study of caregivers. PLOS Glob Public Health. 2023; 3(4):e0001705. PMID: 37014836; PMCID: PMC10072487.
      Citations:    
    6. Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande LF, Kiyaga C, Chunda-Liyoka CM, Awuonda B, Ohene-Frempong K, Inusa BP, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EM. The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology. Blood Adv. 2022 Oct 20. PMID: 36264096.
      Citations: 4     Fields:    
    7. John TD, Namazzi R, Chirande L, Tubman VN. Global perspectives on cellular therapy for children with sickle cell disease. Curr Opin Hematol. 2022 11 01; 29(6):275-280. PMID: 36206076; PMCID: PMC10107365.
      Citations: 2     Fields:    Translation:Humans
    8. Karsenty C, Liu CJ, Fasipe T, Wyatt KEK, Tubman VN. Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series. Pediatr Blood Cancer. 2022 06; 69(6):e29695. PMID: 35373913; PMCID: PMC9172213.
      Citations:    Fields:    Translation:Humans
    9. Archer NM, Inusa B, Makani J, Nkya S, Tubman VN, McGann PT, Ambrose EE, Henrich N, Spector J, Ohene-Frempong K, Tshilolo L. Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open. 2022 03 09; 12(3):e057623. PMID: 35264367; PMCID: PMC8915265.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Han H, Hensch L, Tubman VN. Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):696-703. PMID: 34889416; PMCID: PMC8791131.
      Citations: 1     Fields:    Translation:Humans
    11. Natoli ME, Chang MM, Kundrod KA, Coole JB, Airewele GE, Richards-Kortum RR, Tubman VN. Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings. Anal Chem. 2021 03 23; 93(11):4832-4840. PMID: 33689292; PMCID: PMC7992048.
      Citations: 2     Fields:    Translation:Humans
    12. Coria AL, Taylor CM, Tubman VN. Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs. Am J Trop Med Hyg. 2020 04; 102(4):902-904. PMID: 32043441; PMCID: PMC7124896.
      Citations:    Fields:    Translation:Humans
    13. Tubman VN. Mother knows best: The caregiver's perspective on clinical trials for sickle cell disease highlights the challenges of providing care in Africa. Pediatr Blood Cancer. 2020 02; 67(2):e28054. PMID: 31724295.
      Citations: 1     Fields:    Translation:Humans
    14. Tripodi SI, Shamberger RC, Heeney MM, Tubman VN. Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr Hematol Oncol. 2019 Sep; 36(6):382-389. PMID: 31347415; PMCID: PMC6752974.
      Citations: 1     Fields:    Translation:Humans
    15. Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J, HOPE Trial Investigators. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519. PMID: 31199090.
      Citations: 135     Fields:    Translation:HumansCellsCTClinical Trials
    16. Makani J, Tubman VN. Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions. Br J Haematol. 2017 06; 177(6):938-946. PMID: 28493472; PMCID: PMC5494998.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    17. Koegel AK, Hofmann I, Moffitt K, Degar B, Duncan C, Tubman VN. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 10; 63(10):1844-7. PMID: 27232273.
      Citations: 9     Fields:    Translation:Humans
    18. Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MM, Tubman VN. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study. Pediatr Blood Cancer. 2016 Apr; 63(4):671-6. PMID: 26739520; PMCID: PMC4755789.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    19. Mejia P, Shmukler BE, Bei AK, Alper SL, Mitchell JR, Brugnara C, Duraisingh MT, Tubman VN. The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity. Antimicrob Agents Chemother. 2016 01; 60(1):613-6. PMID: 26459896; PMCID: PMC4704178.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    20. Green AL, Yi J, Bezler N, Pikman Y, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL, Tubman VN. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7. PMID: 26292080.
      Citations: 1     Fields:    Translation:Humans
    21. Fung EB, Vogiatzi M, Thompson AA, Rogers ZR, Neufeld EJ, Kwiatkowski JL, Thalassemia Clinical Research Network, Tubman VN. Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort. J Pediatr Hematol Oncol. 2015 Apr; 37(3):e162-9. PMID: 26201037; PMCID: PMC4511957.
      Citations: 17     Fields:    Translation:Humans
    22. Field JJ, Tubman VN. Sickle solubility test to screen for sickle cell trait: what's the harm? Hematology Am Soc Hematol Educ Program. 2015; 2015:433-5. PMID: 26637754.
      Citations: 3     Fields:    Translation:Humans
    23. McQuilkin P, Marshall RE, Niescierenko M, Olson BG, Staton D, Williams JH, Graham EA, Tubman VN. A Successful US Academic Collaborative Supporting Medical Education in a Postconflict Setting. Glob Pediatr Health. 2014; 1:2333794X14563383. PMID: 27335926; PMCID: PMC4804687.
      Citations: 5     
    24. Archer NM, Tubman VN. Building partnerships to target sickle cell anemia in Africa. Am J Hematol. 2013 Dec; 88(12):983. PMID: 24123084.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    25. Bennett CM, Luo HY, Chui DH, Heeney MM, Tubman VN. Sickle cell disease caused by Hb S/Qu?bec-CHORI: treatment with hydroxyurea and response. Pediatr Blood Cancer. 2007 Aug; 49(2):207-10. PMID: 17551985.
      Citations:    Fields:    Translation:Humans
    26. Smoot L, Heeney MM, Tubman VN. Acquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer. 2007 Mar; 48(3):339-44. PMID: 16435382.
      Citations: 5     Fields:    Translation:HumansCells
    27. Levine JE, Campagna DR, Monahan-Earley R, Dvorak AM, Neufeld EJ, Fleming MD, Tubman VN. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood. 2007 Apr 15; 109(8):3297-9. PMID: 17209061.
      Citations: 30     Fields:    Translation:HumansCells
    TUBMAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (163)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _